MINNEAPOLIS, June 27, 2011 /PRNewswire/ -- BioDrain Medical, Inc. (OTCBB: BIOR, OTCQB: BIOR), producer of the FDA cleared Streamway® System for automated surgical fluid disposal, today announced that it has placed two additional units and that new evaluations are underway at surgical facilities in Minnesota. The Streamway System has received positive reviews and feedback from surgical personnel at both sites.
Healthcare personnel trained in the use of the Streamway System were especially pleased with its ease of use, the efficiency of the automated disposal of surgical fluids, and the minimal risk of exposure to hazardous waste.
Kevin Davidson, CEO of BioDrain, declared, "These evaluations were conducted at two hospitals as part of our normal sales process and contribute to BioDrain's development of its market position. We are very pleased that surgical personnel in these facilities are finding the Streamway System to be a highly efficient and cost-effective means to automatically dispose of surgical waste fluid. This breakthrough system has now been used in over 300 live operations as part of our product launch phase. We are delighted with the enthusiastic response and look forward to further opportunities at these sites as well as other surgical facilities."
About BioDrain Medical, Inc.
BioDrain Medical, Inc. has a fully automated, patented, FDA cleared, surgical fluid disposal system that virtually eliminates operating room workers' exposure to blood, irrigation fluid and the related germs, viruses and diseases that are potentially found in the surgical environment. Today's manual surgical fluid handling methods of hand-carrying filled surgical fluid canisters and emptying these canisters is an exposure risk and an antiquated approach to the handling of surgical fluid waste. BioDrain's Streamway system fully automates the collection, measurement and disposal of surgical fluids resulting in: 1) reducing overhead costs to hospitals and surgical centers, 2) improving the Occupational State and Health Association (OSHA) and other regulatory compliance, and 3) improving the efficiency of the operating room (and thereby making surgeries more profitable).
BioDrain's Streamway System is eco-friendly as it contributes to cleaning up the environment. Currently, approximately 50 million bloody, potentially disease infected, canisters go to landfills annually in the United States. These tainted canisters can remain in landfills for years to come. With the installation of BioDrain's Streamway system, the number of canisters can be significantly reduced. BioDrain Medical, Inc. makes the operating room and our environment safer, cleaner, and better. BioDrain products are currently being represented by independent professional sales representatives that cater to the needs of hospitals and ambulatory surgical centers across the country.
Certain of the matters discussed in this announcement contain forward-looking statements that involve material risks to and uncertainties in the company's business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the company's ability to implement its long range business plan for various applications of its technology; the company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the company's reports filed with the Securities and Exchange Commission. This is not a solicitation to buy or sell securities and does not purport to be an analysis of the Company's financial position. See the Company's most recent Quarterly Report on Form 10-Q and related 8-K filings.
Investor Relations Contact:
Consulting for Strategic Growth 1 Ltd.
Tel: 800-625-2236 ext. 7770
|SOURCE BioDrain Medical, Inc.|
Copyright©2010 PR Newswire.
All rights reserved